摘要
目的:探讨微小RNA(miR)-153-3p如何与α-突触核蛋白(snca)相互作用影响小鼠的骨质疏松进程。方法:采用切除双侧卵巢构建骨质疏松(OVX)小鼠模型(品系),通过苏木精-伊红(HE)染色明确病理学改变。通过实时荧光定量反转录聚合酶链反应、免疫蛋白印记实验和免疫组织化学染色对目标基因的信使RNA(mRNA)及蛋白表达进行定量。核因子-κB活化因子受体配体(RANKL)处理小鼠单核巨噬细胞白血病细胞(RAW264.7细胞)后,显微镜下观察细胞形态,噻唑蓝(MTT)法评价细胞活力,Transwell实验检测破骨细胞迁移能力;双荧光素酶实验验证miR-153-3p与snca的相互作用。结果:snca在OVX小鼠中低表达(t=11.436,P<0.05),miR-153-3p在OVX小鼠中高表达(t=15.833,P<0.05)。抑制miR-153-3p或过表达snca抑制骨质疏松,snca在RANKL诱导的RAW264.7细胞中低表达(t=11.796,P<0.05),miR-153-3p在RANKL诱导的RAW264.7细胞中高表达(t=10.448,P<0.05)。过表达snca抑制破骨细胞分化[抗酒石酸酸性磷酸酶(TRAP):t=7.493,P<0.05;Cathepsin K:t=9.536,P<0.05;基质金属蛋白酶(MMP)-9:t=20.371,P<0.05;MMP-2:t=31.924,P<0.05]。miR-153-3p通过抑制snca表达促进破骨细胞分化(F=123.390,P<0.05),过表达snca能恢复过表达miR-153-3p的效果(F=136.515,P<0.05)。双荧光素酶及蛋白检测实验结果表明miR-153-3p能负向调控snca的表达(F=92.528,P<0.05)。结论:抑制miR-153-3p通过促进snca表达抑制破骨细胞功能,进而抑制小鼠体内骨质疏松进程。
Objective To investigate how the interactions between microRNA(miR)-153-3p andα-synuclein(SNCA)contribute to osteoporosis in mice.Methods The moust osteoporosis(OVX)model was constructed by bilateral ovariectomy,and the pathological changes were confirmed by hematoxylin-eosin(HE)staining.Real-time fluorescent quantitative reverse transcription polymerase chain reaction(RT-qPCR)and Western blotting were used to quantify the messenger RNA(mRNA)and protein expression of target genes.After treating mouse RAW264.7 cells with receptor activator of nuclear factor-κB ligand(RANKL),morphological changes were observed under the microscopy.Methyl thiazolyl tetrazolium(MTT)assay was used to evaluate cell viability,Transwell experiment was used to detect osteoclast migration ability,and dual-luciferase reporter(DLR)assay was used to verify the interaction between miR-153-3p and snca.Results The expression of snca was low in OVX mice(t=11.436,P<0.05),while the expression of miR-153-3p was high(t=15.833,P<0.05).Inhibiting miR-153-3p or overexpressing snca suppressed osteoporosis.The expression of snca was low in RANKL-induced RAW264.7 cells(t=11.796,P<0.05),while the expression of miR-153-3p was high(t=10.448,P<0.05).Overexpression of snca inhibited osteoclast differentiation,evidenced by the expression changes in a series of osteoclast markers[tartrate resistant acid phosphatase(TRAP):t=7.493,P<0.05;Cathepsin K:t=9.536,P<0.05;matrix metalloproteinase(MMP)-9:t=20.371,P<0.05;MMP-2:t=31.924,P<0.05].miR-153-3p promoted osteoclast differentiation by inhibiting snca expression(F=123.390,P<0.05),and overexpression of snca restored the effect of overexpressing miR-153-3p(F=136.515,P<0.05).DLR assay showed that miR-153-3p negatively regulated the expression of snca(F=92.528,P<0.05).Conclusion Inhibition of miR-153-3p suppresses the function of osteoclasts by promoting snca expression,and then inhibits the process of osteoporosis in mice.
作者
娄超举
Lou Chaoju(Department of Orthopaedics,First Affiliated Hospital of Zhengzhou University,Zhengzhou 450000,China)
出处
《中华实验外科杂志》
CAS
2024年第5期1024-1028,共5页
Chinese Journal of Experimental Surgery